Skip to main content

Published locations for FDA approves oral dacomitinib for some metastatic NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves oral dacomitinib for some metastatic NSCLC

User login

  • Reset your password
  • /content/fda-approves-oral-dacomitinib-some-metastatic-nsclc
  • /familypracticenews/article/175962/lung-cancer/fda-approves-oral-dacomitinib-some-metastatic-nsclc
  • /internalmedicinenews/article/175962/lung-cancer/fda-approves-oral-dacomitinib-some-metastatic-nsclc
  • /oncologypractice/article/175962/lung-cancer/fda-approves-oral-dacomitinib-some-metastatic-nsclc
  • /fedprac/avaho/article/175962/lung-cancer/fda-approves-oral-dacomitinib-some-metastatic-nsclc
  • /hematology-oncology/article/175962/lung-cancer/fda-approves-oral-dacomitinib-some-metastatic-nsclc
  • /internalmedicine/article/175962/lung-cancer/fda-approves-oral-dacomitinib-some-metastatic-nsclc
  • /familymedicine/article/175962/lung-cancer/fda-approves-oral-dacomitinib-some-metastatic-nsclc
  • /chestphysician/article/175962/lung-cancer/fda-approves-oral-dacomitinib-some-metastatic-nsclc